Literature DB >> 29279323

The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

Gemma Macchia1, Marco Severgnini2, Stefania Purgato3, Doron Tolomeo4, Hilen Casciaro4, Ingrid Cifola2, Alberto L'Abbate4, Anna Loverro4, Orazio Palumbo5, Massimo Carella5, Laurence Bianchini6, Giovanni Perini3, Gianluca De Bellis2, Fredrik Mertens7, Mariano Rocchi4, Clelia Tiziana Storlazzi4.   

Abstract

Genome amplification in the form of rings or giant rod-shaped marker chromosomes (RGMs) is a common genetic alteration in soft tissue tumors. The mitotic stability of these structures is often rescued by perfectly functioning analphoid neocentromeres, which therefore significantly contribute to cancer progression. Here, we disentangled the genomic architecture of many neocentromeres stabilizing marker chromosomes in well-differentiated liposarcoma and lung sarcomatoid carcinoma samples. In cells carrying heavily rearranged RGMs, these structures were assembled as patchworks of multiple short amplified sequences, disclosing an extremely high level of complexity and definitely ruling out the existence of regions prone to neocentromere seeding. Moreover, by studying two well-differentiated liposarcoma samples derived from the onset and the recurrence of the same tumor, we documented an expansion of the neocentromeric domain that occurred during tumor progression, which reflects a strong selective pressure acting toward the improvement of the neocentromeric functionality in cancer. In lung sarcomatoid carcinoma cells we documented, extensive "centromere sliding" phenomena giving rise to multiple, closely mapping neocentromeric epialleles on separate coexisting markers occur, likely due to the instability of neocentromeres arising in cancer cells. Finally, by investigating the transcriptional activity of neocentromeres, we came across a burst of chimeric transcripts, both by extremely complex genomic rearrangements, and cis/trans-splicing events. Post-transcriptional editing events have been reported to expand and variegate the genetic repertoire of higher eukaryotes, so they might have a determining role in cancer. The increased incidence of fusion transcripts, might act as a driving force for the genomic amplification process, together with the increased transcription of oncogenes.
Copyright © 2018 by the Genetics Society of America.

Entities:  

Keywords:  LSC; WDLPS; fusion transcript; gene amplification; neocentromere

Mesh:

Substances:

Year:  2017        PMID: 29279323      PMCID: PMC5844343          DOI: 10.1534/genetics.117.300552

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  48 in total

1.  BLAT--the BLAST-like alignment tool.

Authors:  W James Kent
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Double-strand DNA breaks recruit the centromeric histone CENP-A.

Authors:  Samantha G Zeitlin; Norman M Baker; Brian R Chapados; Evi Soutoglou; Jean Y J Wang; Michael W Berns; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-28       Impact factor: 11.205

4.  The architecture and evolution of cancer neochromosomes.

Authors:  Dale W Garsed; Owen J Marshall; Vincent D A Corbin; Arthur Hsu; Leon Di Stefano; Jan Schröder; Jason Li; Zhi-Ping Feng; Bo W Kim; Mark Kowarsky; Ben Lansdell; Ross Brookwell; Ola Myklebost; Leonardo Meza-Zepeda; Andrew J Holloway; Florence Pedeutour; K H Andy Choo; Michael A Damore; Andrew J Deans; Anthony T Papenfuss; David M Thomas
Journal:  Cancer Cell       Date:  2014-11-10       Impact factor: 31.743

5.  Application of the Taguchi method to the analysis of the deposition step in microarray production.

Authors:  Marco Severgnini; Linda Pattini; Clarissa Consolandi; Ermanno Rizzi; Cristina Battaglia; Gianluca De Bellis; Sergio Cerutti
Journal:  IEEE Trans Nanobioscience       Date:  2006-09       Impact factor: 2.935

6.  Abundant and broad expression of transcription-induced chimeras and protein products in mammalian genomes.

Authors:  Guanting Lu; Jin Wu; Gangbin Zhao; Zhiqiang Wang; Weihua Chen; Shijie Mu
Journal:  Biochem Biophys Res Commun       Date:  2015-12-21       Impact factor: 3.575

7.  Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas.

Authors:  Barry S Taylor; Penelope L DeCarolis; Christina V Angeles; Fabienne Brenet; Nikolaus Schultz; Cristina R Antonescu; Joseph M Scandura; Chris Sander; Agnes J Viale; Nicholas D Socci; Samuel Singer
Journal:  Cancer Discov       Date:  2011-12       Impact factor: 39.397

8.  Active centromere and chromosome identification in fixed cell lines.

Authors:  Thian T Beh; Ruth N MacKinnon; Paul Kalitsis
Journal:  Mol Cytogenet       Date:  2016-03-22       Impact factor: 2.009

9.  CENP-C and CENP-I are key connecting factors for kinetochore and CENP-A assembly.

Authors:  Nobuaki Shono; Jun-ichirou Ohzeki; Koichiro Otake; Nuno M C Martins; Takahiro Nagase; Hiroshi Kimura; Vladimir Larionov; William C Earnshaw; Hiroshi Masumoto
Journal:  J Cell Sci       Date:  2015-11-02       Impact factor: 5.285

10.  Several fusion genes identified by whole transcriptome sequencing in a spindle cell sarcoma with rearrangements of chromosome arm 12q and MDM2 amplification.

Authors:  Ioannis Panagopoulos; Bodil Bjerkehagen; Ludmila Gorunova; Jeanne-Marie Berner; Kjetil Boye; Sverre Heim
Journal:  Int J Oncol       Date:  2014-08-18       Impact factor: 5.650

View more
  9 in total

1.  Eight million years of maintained heterozygosity in chromosome homologs of cercopithecine monkeys.

Authors:  Doron Tolomeo; Oronzo Capozzi; Giorgia Chiatante; Luca Sineo; Takafumi Ishida; Nicoletta Archidiacono; Mariano Rocchi; Roscoe Stanyon
Journal:  Chromosoma       Date:  2020-01-10       Impact factor: 4.316

2.  The MDM2 inducible promoter folds into four-tetrad antiparallel G-quadruplexes targetable to fight malignant liposarcoma.

Authors:  Sara Lago; Matteo Nadai; Emanuela Ruggiero; Martina Tassinari; Maja Marušič; Beatrice Tosoni; Ilaria Frasson; Filippo M Cernilogar; Valentina Pirota; Filippo Doria; Janez Plavec; Gunnar Schotta; Sara N Richter
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

Review 3.  TP53 in bone and soft tissue sarcomas.

Authors:  Elizabeth Thoenen; Amanda Curl; Tomoo Iwakuma
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 4.  Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.

Authors:  Roel G W Verhaak; Vineet Bafna; Paul S Mischel
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

5.  Canady Cold Helios Plasma Reduces Soft Tissue Sarcoma Viability by Inhibiting Proliferation, Disrupting Cell Cycle, and Inducing Apoptosis: A Preliminary Report.

Authors:  Lawan Ly; Xiaoqian Cheng; Saravana R K Murthy; Olivia Z Jones; Taisen Zhuang; Steven Gitelis; Alan T Blank; Aviram Nissan; Mohammad Adileh; Matthew Colman; Michael Keidar; Giacomo Basadonna; Jerome Canady
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

6.  Cytogenomic Characterization of Giant Ring or Rod Marker Chromosome in Four Cases of Well-Differentiated and Dedifferentiated Liposarcoma.

Authors:  Hongyan Chai; Fang Xu; Autumn DiAdamo; Brittany Grommisch; Huanzhi Mao; Peining Li
Journal:  Case Rep Genet       Date:  2022-04-12

7.  Promoter G-quadruplexes and transcription factors cooperate to shape the cell type-specific transcriptome.

Authors:  Sara Lago; Matteo Nadai; Filippo M Cernilogar; Maryam Kazerani; Helena Domíniguez Moreno; Gunnar Schotta; Sara N Richter
Journal:  Nat Commun       Date:  2021-06-23       Impact factor: 14.919

Review 8.  Small ring has big potential: insights into extrachromosomal DNA in cancer.

Authors:  Yihao Wang; Rui Huang; Guopei Zheng; Jianfeng Shen
Journal:  Cancer Cell Int       Date:  2021-04-26       Impact factor: 5.722

9.  BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features.

Authors:  Doron Tolomeo; Antonio Agostini; Gemma Macchia; Alberto L'Abbate; Marco Severgnini; Ingrid Cifola; Maria Antonia Frassanito; Vito Racanelli; Antonio Giovanni Solimando; Felix Haglund; Fredrik Mertens; Clelia Tiziana Storlazzi
Journal:  Hum Cell       Date:  2020-08-27       Impact factor: 4.174

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.